Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe

Inclusion Criteria: * Patients of the age of 5 years and older suffering from a house dust mite induced allergic rhinitis Exclusion Criteria: * Patients suffering from acute or chronic infections or inflammations * Patients suffering from secondary modifications of the target organ with function impairment (emphysema, bronchiectasis) * Patients suffering from severe and uncontrolled asthma * Patients with a known severe autoimmune disease * Patients with active malignant disease * Patients requiring beta-blockers * Patients having any contraindication for the use of adrenaline * Patients with a hypersensitivity to the excipients of the drug